Subcutaneous maternal resveratrol treatment increases uterine artery blood flow in the pregnant ewe and increases fetal but not cardiac growth

Jack R.T. Darby, Brahmdeep S. Saini, Jia Yin Soo, Mitchell C. Lock, Stacey L. Holman, Emma L. Bradshaw, Steven J.P. McInnes, Nicolas H. Voelcker, Christopher K. Macgowan, Mike Seed, Michael D. Wiese, Janna L. Morrison

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Key points: Substrate restriction during critical developmental windows of gestation programmes offspring for a predisposition towards cardiovascular disease in adult life. This study aimed to determine the effect of maternal resveratrol (RSV) treatment in an animal model in which chronic fetal catheterisation is possible and the timing of organ maturation reflects that of the human. Maternal RSV treatment increased uterine artery blood flow, fetal oxygenation and fetal weight. RSV was not detectable in the fetal circulation, indicating that it may not cross the sheep placenta. This study highlights RSV as a possible intervention to restore fetal substrate supply in pregnancies affected by placental insufficiency. Abstract: Suboptimal in utero environments with reduced substrate supply during critical developmental windows of gestation predispose offspring to non-communicable diseases such as cardiovascular disease (CVD). Improving fetal substrate supply in these pregnancies may ameliorate the predisposition these offspring have toward adult-onset CVD. This study aimed to determine the effect of maternal resveratrol (RSV) supplementation on uterine artery blood flow and the direct effects of RSV on the fetal heart in a chronically catheterised sheep model of human pregnancy. Maternal RSV treatment significantly increased uterine artery blood flow as measured by phase contrast magnetic resonance imaging, mean gestational fetal PaO2 and SaO2 as well as fetal weight. RSV was not detectable in the fetal circulation, and mRNA and protein expression of the histone/protein deacetylase SIRT1 did not differ between treatment groups. No effect of maternal RSV supplementation on AKT/mTOR or CAMKII signalling in the fetal left ventricle was observed. Maternal RSV supplementation is capable of increasing fetal oxygenation and growth in an animal model in which cardiac development parallels that of the human.

Original languageEnglish
Pages (from-to)5063-5077
Number of pages15
JournalJournal of Physiology
Volume597
Issue number20
DOIs
Publication statusPublished - 1 Oct 2019

Keywords

  • fetus
  • heart
  • MRI
  • resveratrol
  • uterine artery blood flow

Cite this

Darby, J. R. T., Saini, B. S., Soo, J. Y., Lock, M. C., Holman, S. L., Bradshaw, E. L., ... Morrison, J. L. (2019). Subcutaneous maternal resveratrol treatment increases uterine artery blood flow in the pregnant ewe and increases fetal but not cardiac growth. Journal of Physiology, 597(20), 5063-5077. https://doi.org/10.1113/JP278110
Darby, Jack R.T. ; Saini, Brahmdeep S. ; Soo, Jia Yin ; Lock, Mitchell C. ; Holman, Stacey L. ; Bradshaw, Emma L. ; McInnes, Steven J.P. ; Voelcker, Nicolas H. ; Macgowan, Christopher K. ; Seed, Mike ; Wiese, Michael D. ; Morrison, Janna L. / Subcutaneous maternal resveratrol treatment increases uterine artery blood flow in the pregnant ewe and increases fetal but not cardiac growth. In: Journal of Physiology. 2019 ; Vol. 597, No. 20. pp. 5063-5077.
@article{a16cd5e7506d4d61a4038118b28ec56d,
title = "Subcutaneous maternal resveratrol treatment increases uterine artery blood flow in the pregnant ewe and increases fetal but not cardiac growth",
abstract = "Key points: Substrate restriction during critical developmental windows of gestation programmes offspring for a predisposition towards cardiovascular disease in adult life. This study aimed to determine the effect of maternal resveratrol (RSV) treatment in an animal model in which chronic fetal catheterisation is possible and the timing of organ maturation reflects that of the human. Maternal RSV treatment increased uterine artery blood flow, fetal oxygenation and fetal weight. RSV was not detectable in the fetal circulation, indicating that it may not cross the sheep placenta. This study highlights RSV as a possible intervention to restore fetal substrate supply in pregnancies affected by placental insufficiency. Abstract: Suboptimal in utero environments with reduced substrate supply during critical developmental windows of gestation predispose offspring to non-communicable diseases such as cardiovascular disease (CVD). Improving fetal substrate supply in these pregnancies may ameliorate the predisposition these offspring have toward adult-onset CVD. This study aimed to determine the effect of maternal resveratrol (RSV) supplementation on uterine artery blood flow and the direct effects of RSV on the fetal heart in a chronically catheterised sheep model of human pregnancy. Maternal RSV treatment significantly increased uterine artery blood flow as measured by phase contrast magnetic resonance imaging, mean gestational fetal PaO2 and SaO2 as well as fetal weight. RSV was not detectable in the fetal circulation, and mRNA and protein expression of the histone/protein deacetylase SIRT1 did not differ between treatment groups. No effect of maternal RSV supplementation on AKT/mTOR or CAMKII signalling in the fetal left ventricle was observed. Maternal RSV supplementation is capable of increasing fetal oxygenation and growth in an animal model in which cardiac development parallels that of the human.",
keywords = "fetus, heart, MRI, resveratrol, uterine artery blood flow",
author = "Darby, {Jack R.T.} and Saini, {Brahmdeep S.} and Soo, {Jia Yin} and Lock, {Mitchell C.} and Holman, {Stacey L.} and Bradshaw, {Emma L.} and McInnes, {Steven J.P.} and Voelcker, {Nicolas H.} and Macgowan, {Christopher K.} and Mike Seed and Wiese, {Michael D.} and Morrison, {Janna L.}",
year = "2019",
month = "10",
day = "1",
doi = "10.1113/JP278110",
language = "English",
volume = "597",
pages = "5063--5077",
journal = "The Journal of Physiology",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "20",

}

Darby, JRT, Saini, BS, Soo, JY, Lock, MC, Holman, SL, Bradshaw, EL, McInnes, SJP, Voelcker, NH, Macgowan, CK, Seed, M, Wiese, MD & Morrison, JL 2019, 'Subcutaneous maternal resveratrol treatment increases uterine artery blood flow in the pregnant ewe and increases fetal but not cardiac growth', Journal of Physiology, vol. 597, no. 20, pp. 5063-5077. https://doi.org/10.1113/JP278110

Subcutaneous maternal resveratrol treatment increases uterine artery blood flow in the pregnant ewe and increases fetal but not cardiac growth. / Darby, Jack R.T.; Saini, Brahmdeep S.; Soo, Jia Yin; Lock, Mitchell C.; Holman, Stacey L.; Bradshaw, Emma L.; McInnes, Steven J.P.; Voelcker, Nicolas H.; Macgowan, Christopher K.; Seed, Mike; Wiese, Michael D.; Morrison, Janna L.

In: Journal of Physiology, Vol. 597, No. 20, 01.10.2019, p. 5063-5077.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Subcutaneous maternal resveratrol treatment increases uterine artery blood flow in the pregnant ewe and increases fetal but not cardiac growth

AU - Darby, Jack R.T.

AU - Saini, Brahmdeep S.

AU - Soo, Jia Yin

AU - Lock, Mitchell C.

AU - Holman, Stacey L.

AU - Bradshaw, Emma L.

AU - McInnes, Steven J.P.

AU - Voelcker, Nicolas H.

AU - Macgowan, Christopher K.

AU - Seed, Mike

AU - Wiese, Michael D.

AU - Morrison, Janna L.

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Key points: Substrate restriction during critical developmental windows of gestation programmes offspring for a predisposition towards cardiovascular disease in adult life. This study aimed to determine the effect of maternal resveratrol (RSV) treatment in an animal model in which chronic fetal catheterisation is possible and the timing of organ maturation reflects that of the human. Maternal RSV treatment increased uterine artery blood flow, fetal oxygenation and fetal weight. RSV was not detectable in the fetal circulation, indicating that it may not cross the sheep placenta. This study highlights RSV as a possible intervention to restore fetal substrate supply in pregnancies affected by placental insufficiency. Abstract: Suboptimal in utero environments with reduced substrate supply during critical developmental windows of gestation predispose offspring to non-communicable diseases such as cardiovascular disease (CVD). Improving fetal substrate supply in these pregnancies may ameliorate the predisposition these offspring have toward adult-onset CVD. This study aimed to determine the effect of maternal resveratrol (RSV) supplementation on uterine artery blood flow and the direct effects of RSV on the fetal heart in a chronically catheterised sheep model of human pregnancy. Maternal RSV treatment significantly increased uterine artery blood flow as measured by phase contrast magnetic resonance imaging, mean gestational fetal PaO2 and SaO2 as well as fetal weight. RSV was not detectable in the fetal circulation, and mRNA and protein expression of the histone/protein deacetylase SIRT1 did not differ between treatment groups. No effect of maternal RSV supplementation on AKT/mTOR or CAMKII signalling in the fetal left ventricle was observed. Maternal RSV supplementation is capable of increasing fetal oxygenation and growth in an animal model in which cardiac development parallels that of the human.

AB - Key points: Substrate restriction during critical developmental windows of gestation programmes offspring for a predisposition towards cardiovascular disease in adult life. This study aimed to determine the effect of maternal resveratrol (RSV) treatment in an animal model in which chronic fetal catheterisation is possible and the timing of organ maturation reflects that of the human. Maternal RSV treatment increased uterine artery blood flow, fetal oxygenation and fetal weight. RSV was not detectable in the fetal circulation, indicating that it may not cross the sheep placenta. This study highlights RSV as a possible intervention to restore fetal substrate supply in pregnancies affected by placental insufficiency. Abstract: Suboptimal in utero environments with reduced substrate supply during critical developmental windows of gestation predispose offspring to non-communicable diseases such as cardiovascular disease (CVD). Improving fetal substrate supply in these pregnancies may ameliorate the predisposition these offspring have toward adult-onset CVD. This study aimed to determine the effect of maternal resveratrol (RSV) supplementation on uterine artery blood flow and the direct effects of RSV on the fetal heart in a chronically catheterised sheep model of human pregnancy. Maternal RSV treatment significantly increased uterine artery blood flow as measured by phase contrast magnetic resonance imaging, mean gestational fetal PaO2 and SaO2 as well as fetal weight. RSV was not detectable in the fetal circulation, and mRNA and protein expression of the histone/protein deacetylase SIRT1 did not differ between treatment groups. No effect of maternal RSV supplementation on AKT/mTOR or CAMKII signalling in the fetal left ventricle was observed. Maternal RSV supplementation is capable of increasing fetal oxygenation and growth in an animal model in which cardiac development parallels that of the human.

KW - fetus

KW - heart

KW - MRI

KW - resveratrol

KW - uterine artery blood flow

UR - http://www.scopus.com/inward/record.url?scp=85073183869&partnerID=8YFLogxK

U2 - 10.1113/JP278110

DO - 10.1113/JP278110

M3 - Article

C2 - 31483497

AN - SCOPUS:85073183869

VL - 597

SP - 5063

EP - 5077

JO - The Journal of Physiology

JF - The Journal of Physiology

SN - 0022-3751

IS - 20

ER -